← Leaderboards
Amy Lynn Spoering
Novobiotic Pharmaceuticals, Llc
$8,494,670
Attributed
$8,494,670
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2010–24$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,494,670 · 8
By mechanism
R43$3,199,284 · 6
R44$2,967,717 · 1
P01$2,327,669 · 1
Top collaborators
No co-investigators on record.
Most similar at Novobiotic Pharmaceuticals, Llc
Same institution · by research overlap
- Dallas Hughes$18,700,713
- Losee Lucy Ling$17,993,656
Others in their field
Top investigators on “Source”
- Richard A Gibbs · Baylor College Of Medicine$285,393,445
- David Heimbrook · Leidos Biomedical Research, Inc.$233,184,481
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Jeffrey P Krischer · University Of South Florida$224,745,020
- Albert Lazzarini · California Institute Of Technology$202,317,285
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$155,571,437
Research focus
SourcePathogenMicroorganismAntibioticsStaphylococcus AureusBacteriaCytotoxicityCollectionMicrobialAntimicrobialEscherichia ColiBaseFractionationActinobacteria ClassLeadPropertyValidationSoilDrug ResistanceDrug DiscoveryOrganismIncubatedIn SituIn Vitro
Grant awards (19)
Antifungal discovery from previously uncultivated bacteria$295,757
R43 · FY2024 · AI · contact PI
Antifungal discovery from previously uncultivated bacteria$299,997
R43 · FY2023 · AI · contact PI
Antibiotic discovery from a new genus of uncultured bacteria.$296,521
R43 · FY2021 · AI · contact PI
Uncultured bacteria for the discovery of novel antimicrobials$453,409
P01 · FY2020 · AI · contact PI
Antibiotic discovery from a new genus of uncultured bacteria.$299,505
R43 · FY2020 · AI · contact PI
Uncultured bacteria for the discovery of novel antimicrobials$437,659
P01 · FY2019 · AI · contact PI
Uncultured bacteria for the discovery of novel antimicrobials$464,848
P01 · FY2018 · AI · contact PI
Novel Antibiotics from Marine Invertebrate Microbes$300,000
R43 · FY2018 · AI · contact PI
Uncultured bacteria for the discovery of novel antimicrobials$447,392
P01 · FY2017 · AI · contact PI
Novel Antibiotics from Marine Invertebrate Microbes$286,229
R43 · FY2017 · AI · contact PI
Uncultured bacteria for the discovery of novel antimicrobials$524,361
P01 · FY2016 · AI · contact PI
Drug Discovery from Slow Growing and Rare Microbial Species$981,599
R44 · FY2015 · AI · contact PI
Microbial symbionts of marine invertebrates for antibiotic discovery$224,356
R43 · FY2015 · AI · contact PI
Drug Discovery from Slow Growing and Rare Microbial Species$986,467
R44 · FY2014 · AI · contact PI
Drug Discovery from Slow Growing and Rare Microbial Species$999,651
R44 · FY2013 · AI · contact PI
High throughput antibiotic discovery from the uncultivated microbial majority.$299,867
R43 · FY2011 · AI · contact PI
Drug Discovery from Slow Growing and Rare Microbial Species$299,559
R43 · FY2011 · AI · contact PI
Drug Discovery from Slow Growing and Rare Microbial Species$299,417
R43 · FY2010 · AI · contact PI
High throughput antibiotic discovery from the uncultivated microbial majority.$298,076
R43 · FY2010 · AI · contact PI